News

PolyNovo's NovoSorb BTM delivers positive first in human results in diabetes May 14, 2025

PolyNovo (ASX:PNV) has announced that Professor Toby Coates AO, the director of Beta Cell Technologies, has presented the results of the company's NovoSorb and its potential role in treating and managing Type 1 diabetes.

Amplia reports updated positive data from ACCENT trial in pancreatic cancer May 14, 2025

Amplia Therapeutics (ASX:ATX) has announced updated data from its ongoing ACCENT clinical trial of its narmafotinib in combination with chemotherapies gemcitabine and abraxane in pancreatic cancer.

Immutep’s efti with PD-L1 and chemotherapy achieves high response rates in lung cancer May 14, 2025

Immutep (ASX:IMM) has announced that a 60.8 per cent response rate and 90.2 per cent disease control rate have been achieved in the investigator-initiated INSIGHT-003 trial as of the data-cut-off date of 6 May.

CSL Behring wins major international pharmaceutical engineering award May 14, 2025

CSL Behring’s new plasma processing facility in Melbourne has been named the 2025 Facility of the Year in the Pharma 4.0 category by the International Society for Pharmaceutical Engineering.

Lumos advances FebriDx sales with iMedical purchase order May 14, 2025

Point-of-care diagnostic technology company Lumos Diagnostics (ASX:LDX) states that it has received a purchase order and shipped the product for FebriDx to iMedical.

PolyNovo's NovoSorb BTM delivers positive first in human results in diabetes May 14, 2025

PolyNovo (ASX:PNV) has announced that Professor Toby Coates AO, the director of Beta Cell Technologies, has presented the results of the company's NovoSorb and its potential role in treating and managing Type 1 diabetes.

EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy May 12, 2025

EnGeneIC has announced the dosing of the first patient in its open-label, multicentre, Phase I/IIa clinical trial at Mater Hospital in Sydney.

Australia gets a new minister for industry, innovation and science May 12, 2025

Prime Minister Anthony Albanese has appointed Senator Tim Ayres to the industry, innovation and science portfolios.

PolyNovo announces TGA clearance for NovoSorb MTX and enters trading halt May 12, 2025

PolyNovo (ASX:PNV) has announced that its NovoSorb MTX (4 mm, 6 mm) has received TGA clearance, following the regulator's clearance of the 2 mm product in March.

Monash scientists secure MRFF funding to find new medicines for dementia by 'lighting up' human brain cells May 12, 2025

A team of Melbourne scientists has been backed by the Australian Government’s Medical Research Future Fund Stem Cell Therapies Mission to support their development of potential new medicines to treat dementia.

Radiopharm Theranostics accelerates 177Lu-RAD204 Phase 1 dose escalation trial May 12, 2025

Radiopharm Theranostics (ASX:RAD) has achieved a milestone in its ongoing clinical development program for its radiotherapeutic asset, 177Lu-RAD204.

Experienced industry executive appointed chair of Tryptamine Therapeutics May 12, 2025

Clinical-stage company Tryptamine Therapeutics (ASX:TYP) has announced the appointment of Herwig Janssen as its non-executive chairman.

Most Read

New Stories

PolyNovo's NovoSorb BTM delivers positive first in human results in diabetes

Amplia reports updated positive data from ACCENT trial in pancreatic cancer

Immutep’s efti with PD-L1 and chemotherapy achieves high response rates in lung cancer

CSL Behring wins major international pharmaceutical engineering award

Lumos advances FebriDx sales with iMedical purchase order

PolyNovo's NovoSorb BTM delivers positive first in human results in diabetes

EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy

Sign In

Most Read

Follow Us

New Stories

PolyNovo's NovoSorb BTM delivers positive first in human results in diabetes

Amplia reports updated positive data from ACCENT trial in pancreatic cancer

Immutep’s efti with PD-L1 and chemotherapy achieves high response rates in lung cancer

CSL Behring wins major international pharmaceutical engineering award

Lumos advances FebriDx sales with iMedical purchase order

PolyNovo's NovoSorb BTM delivers positive first in human results in diabetes

EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy